Opportunities and challenges related to ferroptosis in glioma and neuroblastoma

Huizhong Chi1,2, Boyan Li1,2, Qingtong Wang1,2

  • 1Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, Shandong, China.

Frontiers in Oncology
|March 20, 2023
PubMed

Insights

Ferroptosis, a cell death pathway involving iron and lipid peroxidation, shows promise for treating glioma and neuroblastoma. This review covers ferroptosis inducers, mechanisms, and its links to immunotherapy and drug resistance.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Ferroptosis is an iron-dependent form of cell death involving lipid peroxidation.
  • Recent research highlights ferroptosis's potential in treating glioma and neuroblastoma.

Purpose of the Study:

  • To review ferroptosis-related therapies for glioblastoma and neuroblastoma.
  • To outline the mechanisms of ferroptosis in these cancers.
  • To summarize current research on ferroptosis inducers and related genes.

Main Methods:

  • Literature review of ferroptosis research in glioma and neuroblastoma.
  • Analysis of traditional drugs, natural compounds, and nanomedicines as ferroptosis inducers.
  • Examination of bioinformatic data on ferroptosis-related genes.

Main Results:

  • Ferroptosis mechanisms in glioma and neuroblastoma are being elucidated.
  • Various agents, including drugs, natural compounds, and nanomedicines, can induce ferroptosis.
  • Ferroptosis is linked to tumor immunotherapy and resistance to temozolomide (TMZ).

Conclusions:

  • Ferroptosis represents a promising therapeutic strategy for glioma and neuroblastoma.
  • Further research is needed to address unresolved issues and optimize ferroptosis-based treatments.
  • Understanding ferroptosis's role in immunotherapy and drug resistance is crucial for clinical applications.

Related Concept Videos